If you’re a visionary leader at a growth stage biopharma company, I help you identify a calculated and informed path to scale — one that mitigates risk, maximizes value, and capitalizes on your existing successes.

My frameworks provide a proven path to sustainable growth and enhanced enterprise value by overcoming common challenges, such as:

-Revenue plateaus
-Operational disruption
-Risk exposure

This stops leaders of biopharma companies from achieving:

-Sustainable growth
-Operational scalability
-Proper risk identification and management

📈 HOW I GET RESULTS FOR MY CLIENTS

As a trusted Business Advisor with decades of experience in the life sciences sector, I help small to midsize Biopharma companies achieve sustainable growth, accelerate time to market, and mitigate risks - allowing industry leaders to put their stamp on their company’s future!

→ Maximize the value of your acquisition or strategic alliance, expedite functional due diligence and time to close, and integrate seamlessly.

→ Accelerate time to market and maximize your enterprise value.

→ Mitigate risk and limit exposure that is inevitable in the growth lifecycle of your company.

✅ WHO I WORK WITH

Founders and Executives of growth stage Biopharma companies who are:

-Balancing aggressive growth targets and practicalities of limited resources
-Looking to maximize the value of a strategic acquisition or industry alliance
-Concerned about potential operational risks through the growth lifecycle
-Working to improve enterprise value to attract further investment

Non-Executive Board Member. Medical Device and Clinical Trials CEO for multiple companies. Strengths are Strategy, Talent ID, Team Building and Growing businesses at accelerated rates.